Related Experiment Videos
Summary
Gelatin gel beads (GGB) proved effective and safe for kidney embolization in dogs. This biocompatible embolic agent demonstrated vessel occlusion and minimal inflammation, paving the way for human trials.
Area of Science:
- Biomaterials Science
- Interventional Radiology
Background:
- Gelatin gel beads (GGB) are cross-linked polypeptides developed for embolic therapy.
- Previous rat studies indicated no acute toxicity, prompting further investigation.
Purpose of the Study:
- To evaluate the efficacy and safety of GGB as an embolic agent in canine kidneys.
- To assess the long-term effects of GGB embolization.
Main Methods:
- Transcatheter embolization of one kidney in eight dogs using 500 mg of GGB suspension with contrast material.
- Post-procedure examination of embolized kidneys over one to five weeks.
Main Results:
- Consistent occlusion of embolized vessels was observed up to five weeks.
- A mild granulomatous reaction was noted, with organization beginning around week three.
- GGB's availability in various sizes and its mixture in isotonic solution offer unique advantages.
Conclusions:
- Gelatin gel beads (GGB) are a safe and reliable embolic agent in canine models.
- The findings support the progression of GGB to human clinical trials for embolization procedures.